Childrens Leukemia Research Assn Inc (EIN 112106778) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1966

Legal Domicile

Phone

5162221944

Tax Period

2024-01-01 to 2024-12-31

Childrens Leukemia Research Assn Inc, founded in 1966, is a small nonprofit that reported $129K in total revenue in fiscal year 2024. Revenue fell 46% from the prior year — a significant decline worth monitoring. Expenses of $664K exceeded revenue, resulting in a 414% operating deficit.

Mission

TO SUPPORT RESEARCH EFFORTS TOWARDS FINDING THE CAUSES AND A CURE FOR LEUKEMIA AND ASSIST FAMILIES IN MEETING THE FINANCIAL OBLIGATIONS INCURRED IN LEUKEMIA TREATMENT.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $154,906

Program Service Revenue $0

Investment Income $-25,835

Other Revenue $0

TOTAL REVENUE $129,071

Expense Breakdown

Grants Paid $180,000

Salaries & Benefits $118,427

Fundraising Expenses $24,553

Program Expenses $596,588

Other Expenses $365,479

TOTAL EXPENSES $663,906

Year-over-Year Comparison

	2024	2023	Change
Revenue	$129,071	$238,347	-0.5%
Expenses	$663,906	$575,022	+0.2%
Net Income	$-534,835	$-336,675	+0.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$56,077

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
TARA COLEMAN	Executive Dir.	35.00	Officer	$56,077	$0	$56,077
PASQUALE ALESIA	President	2.00	Director	$0	$0	$0
CAROL A HASSETT PHD	Vice President	1.00	Director	$0	$0	$0
TAMMY LEGRYS	Secretary	1.00	Director	$0	$0	$0
JOHN DIGILIO JR	Treasurer	1.00	Director	$0	$0	$0
Anthony R Pasqua	Pres EMERITUS	0.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$129,071	$663,906	$516,052	$-534,835
2023	$238,347	$575,022	$978,306	$-336,675
2022	$221,028	$581,850	$1,370,296	$-360,822
2021	$360,724	$468,167	$2,024,378	$-107,443
2020	$122,000	$622,517	$2,182,466	$-500,517
2019	$276,391	$549,295	$2,664,888	$-272,904
2018	$261,458	$555,210	$2,744,691	$-293,752

Childrens Leukemia Research Assn Inc